With 23andMe filing for bankruptcy in March, many users have started to question the safety of their private information.

From my colleague Andrew Joseph: After a bumpy road, Eisai and Biogen’s Alzheimer’s therapy Leqembi has won approval in ...

Chairman Comer investigates 23andMe's bankruptcy over data privacy concerns, focusing on risks to genetic information ...

The investigation comes after the genetic testing company filed for bankruptcy earlier this year, raising questions about the ...